MDLN EBITDA | Medline Inc.

Medline Inc. (MDLN) EBITDA

2026-06-27: Basis Reported; EBITDA $651.00M*; Operating income $395.00M; Depreciation and amortization $256.00M*.
2026-03-28: Basis Reported; EBITDA $676M; Operating income (m); Depreciation and amortization (m).
2025-06-28: Basis Reported; EBITDA $892.00M*; Operating income $642.00M; Depreciation and amortization $250.00M*.
2025-03-29: Basis Reported; EBITDA $818M; Operating income (m); Depreciation and amortization (m).

Complete source-backed ebitda history.

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-27	Reported	$651.00M*	$395.00M	$256.00M*	(m)	(m)	$111.00M*	$715.00M*	$5.47B	(m)	$1.29B	$96.00M
2026-03-28	Reported	$676M	(m)	(m)	(m)	9.19%	$96.00M	$412.00M	$5.51B	(m)	$1.23B	$52.00M
2025-06-28	Reported	$892.00M*	$642.00M	$250.00M*	(m)	(m)	$110.00M*	$197.00M*	$4.98B	(m)	$1.07B	$26.00M
2025-03-29	Reported	$818M	(m)	(m)	(m)	12.31%	$98.00M	$682.00M	$4.82B	(m)	$1.07B	$16.00M

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	$3.22B	(m)	(m)	(m)	11.34%	$447.00M	$1.74B	$20.91B	$80.00M	$4.52B	$91.00M
2024-12-31	Reported	$3.12B	(m)	(m)	(m)	12.24%	$354.00M	$1.77B	$18.53B	$67.00M	$4.11B	$46.00M
2023-12-31	Reported	$2.2B	(m)	(m)	(m)	9.47%	$275.00M	$1.69B	$17.35B	$60.00M	$3.87B	$30.00M